Twelve New ICD-10-PCS Hospital Procedure Codes Released for COVID-19 Treatment
Twelve New ICD-10-PCS Hospital Procedure Codes Released for COVID-19 Treatment – AHIMA and AHA Update FAQs
The unprecedented events of the COVID-19 pandemic have resulted in another unprecedented event: the release of new ICD-10-PCS codes that will be put in use immediately – effective with discharges on or after August 1, 2020, rather than the usual effective date of October 1 (CMS, 2020). In addition, immediate reporting of the new hospital procedure codes for COVID-19 will allow for tracking of the use and effectiveness of these therapies in treating inpatients for COVID-19 and provide valuable information as the nation continues to deal with the disease.
Table of New Codes
The 12 codes are from the New Technology Section X of ICD-10-PCS and are available in the table below. Codes are available for the introduction or infusion of Remdesivir, Sarilumab, Tocilizumab, or other therapeutic substances, as well as the transfusion of convalescent plasma specifically for the treatment of COVID-19.
| Code | Description |
| XW033E5 | Introduction of Remdesivir Anti-Infective into Peripheral Vein, Percutaneous Approach New Technology Group 5 |
| XW043E5 | Introduction of Remdesivir Anti-Infective into Central Vein, Percutaneous Approach New Technology Group 5 |
| XW033G5 | Introduction of Sarilumab Anti-Infective into Peripheral Vein, Percutaneous Approach New Technology Group 5 |
| XW043G5 | Introduction of Sarilumab Anti-Infective into Central Vein, Percutaneous Approach New Technology Group 5 |
| XW033H5 | Introduction of Tocilizumab Anti-Infective into Peripheral Vein, Percutaneous Approach New Technology Group 5 |
| XW043H5 | Introduction of Tocilizumab Anti-Infective into Central Vein, Percutaneous Approach New Technology Group 5 |
| XW013F5 | Introduction of Other New Technology Therapeutic Substance into Subcutaneous Tissue, Percutaneous Approach New Technology Group 5 |
| XW033F5 | Introduction of Other New Technology Therapeutic Substance into Peripheral Vein, Percutaneous Approach New Technology Group 5 |
| XW043F5 | Introduction of Other New Technology Therapeutic Substance into Central Vein, Percutaneous Approach New Technology Group 5 |
| XW0DXF5 | Introduction of Other New Technology Therapeutic Substance into Mouth or Pharynx, External Approach New Technology Group 5 |
| XW13325 | Transfusion of Convalescent Plasma (Nonautologous) into Peripheral Vein, Percutaneous Approach New Technology Group 5 |
| XW14325 | Transfusion of Convalescent Plasma (Nonautologous) into Central Vein, Percutaneous Approach New Technology Group 5 |
Details About the 2020 Codes
Note that the ICD-10-PCS codes 2020 apply to inpatient admissions and should only be used to reflect treatment for COVID-19. Codes from sections other than New Technology, such as the Administration section, should be used if the treatment is not specifically for COVID-19. Furthermore, MS-DRG assignment will not be affected by the reporting of these new COVID-19 treatment codes.
The “Frequently Asked Questions Regarding ICD-10-CM/PCS Coding For COVID-19” document prepared by AHIMA and AHA has also been updated (AHA Coding Clinic Advisor, 2020). In addition, there are now a total of 42 questions with recommended coding for each. The last five questions discuss the new COVID-19 ICD-10-PCS codes just released. Other topics in the revised document include coding for re-admissions of COVID-19 patients, sequela and personal history of COVID-19 and multisystem inflammatory syndrome (MIS-C) due to COVID-19.
Note that some of the original questions and answers have been revised, the most current version is v11. Additionally, revision dates, if applicable, are noted in the FAQ document.
Additional Seven ICD-10-PCS Treatment Codes Effective April 1, 2022
CMS released seven new ICD-10-PCS codes to address COVID-19 treatments in November 2021. The treatment codes will be effective starting April 1, 2022. These codes have been designated as Non-OR and will not affect MS-DRG assignment.
| Code | Description |
| XW013V7 | Introduction of COVID-19 vaccine dose 3 into subcutaneous tissue, percutaneous approach, new technology group |
| XW013W7 | Introduction of COVID-19 vaccine booster into subcutaneous tissue, percutaneous approach, new technology group 7 |
| XW023V7 | Introduction of COVID-19 vaccine dose 3 into muscle, percutaneous approach, new technology group 7 |
| XW023W7 | Introduction of COVID-19 vaccine booster into muscle, percutaneous approach, new technology group 7 |
| XW0DXR7 | Introduction of fostamatinib into mouth and pharynx, external approach, new technology group 7 |
| XW0G7R7 | Introduction of fostamatinib into upper GI, via natural or artificial opening, new technology group 7 |
| XW0H7R7 | Introduction of fostamatinib into lower GI, via natural or artificial opening, new technology group 7 |
Review the code tables, guidelines, and other information for the seven 2022 ICD-10-PCS COVID-19 codes here. Additional information is available here: “AHIMA/AHA Update FAQ Documents for COVID-19 Coding” and “CMS Announces New ICD-10 Codes for Vaccination and COVID-19 Treatments.”
Additional Information
In addition, AMA released the CPT code 87426 for antigen testing in June 2020. Review our COVID-19 Explained article series, which dives into how to code the screening for suspected COVID-19 infection, how to code possible infection and symptoms, and the history and background on COVID-19.
Furthermore, you can review these additional articles for COVID-19 coding and reporting information:
- Provisional Codes Now Available to Report Pfizer COVID-19 Vaccine for Young Children
- AMA Announces Administration Code for Third Dose of Pediatric Pfizer COVID-19 Vaccine
- As More Americans Get COVID-19 Shots, Vaccine Codes are a Priority
- 2022 CPT Code Updates Feature 24 COVID-19 Vaccine-Related Codes
- 2022 ICD 10 CM Updates Now Available – Post COVID-19 Codes Included
- AMA Releases CPT Codes for Novavax COVID-19 Vaccine
- How to Code COVID-19 Treatment
- Updates to FAQs for COVID-19 Immunization Reactions
- COVID-19 Coding Update Course Reviews New ICD-10 Codes & Guidelines
- How to Code Post-COVID-19 Recovery Programs
- Third Group of CPT COVID-19 Vaccine Coding Guidelines from AMA
- 27 New ICD-10 Codes for COVID-19 Related Conditions
- Review These New CPT Codes for COVID-19 Vaccines for the AMA
- Update on Billing COVID-19 Vaccine
- New CPT Codes Released & Revised to Document COVID-19 & Respiratory Syncytial Virus Detection Test
- Latest CPT Codes 86413 & 99072 Report COVID-19 Special Services & Tests
- Four New CPT Codes for Lab Tests Available Now in Latest COVID-19 Documentation Update
- AMA Releases Two New CPT Codes for COVID-19 Antibody Detection
- CDC Releases Updated Coding & Reporting Guidelines for Code U07.1, COVID-19, Effective April 1 Through September 30
- Selecting the Right COVID-19 Code: Should You Use CPT or HCPCS?
- Medical Coding and Billing Tips for COVID-19
- New COVID-19 MS-DRG Assignment, Effective April 1
Education on New Hospital Procedure Codes for COVID-19
Additionally, do you want to learn how to apply the new 2022 ICD-10 COVID-19 codes? Sign up for our COVID-19 ICD-10 Coding Learning Path and find out how to code Coronavirus infections, symptoms, screening, post-COVID-19 condition, treatments and vaccines. The webinar also provides an update to the FY2022 Official Coding Guidelines for COVID-19.
